Tradestie Institutional Equity Comparison Engine

SVRA vs CAPR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SVRA Overall Edge

SVRA Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Savara Inc. (SVRA) driven by superior Valuation, Options & Structure while CAPR counters with relative strength in Momentum & Technical. Fundamentally, SVRA trades at 0.4x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CAPR at 78.7x Forward P/E and 0.0% operating margin (-7.9% YoY). In options structure, SVRA sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SVRA
SVRA 0.4x vs CAPR 78.7x Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs -7.9%
Momentum & Technical Winner CAPR
1Y +3.9% vs +44.3% ยท 52W Pos 13% vs 15%
Options & Structure Winner SVRA
BREAKDOWN (17th %ile IV) vs CONSOLIDATION (89th %ile IV)
SVRA NASDAQ
Savara Inc.
Pharmaceutical Preparations
$4.42
-4.63% 1D
Market Cap $1.1B
1M Return -0.56%
1Y Return +3.87%
Forward P/E 0.4x
Unified AI Score
57.7 / 100 HOLD
Tech 42.0 Fund 54.0 Flow 70.0 Mom 54.0
CAPR NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap $595.4M
1M Return +26.23%
1Y Return +44.29%
Forward P/E 78.7x
Unified AI Score
28.0 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SVRA +3.87% CAPR +44.29% Spread: +42.92 pp (CAPR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SVRA Revenue CAPR Revenue SVRA Op. Margin CAPR Op. Margin Margin Edge
FY2017 N/A $0M N/A -482.4% CAPR
FY2018 N/A $0M N/A -917.0% CAPR
FY2019 N/A $0M N/A -769.5% CAPR
FY2020 $0M $0M -19182.9% -4412.6% CAPR
FY2021 N/A $0M N/A -8549.9% CAPR
FY2022 N/A $0M N/A -1163.9% CAPR
FY2023 N/A $30M N/A -95.6% CAPR
FY2024 N/A $20M N/A -191.1% CAPR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SVRA (6) vs CAPR (2)
Institutional Metric SVRA CAPR Criterion Row Winner
Market Capitalization Scale $1.1B $595.4M Larger Scale SVRA
Trailing P/E Ratio Valuation 0.4x 78.7x Lower Multiple SVRA
Forward P/E Ratio Valuation 0.4x 78.7x Lower Multiple SVRA
Revenue Growth (YoY) Growth +0.0% -7.9% Higher Growth SVRA
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -151.0% -100.5% Higher ROE CAPR
52-Week Range Position Momentum 13% ($4โ€“$7) 15% ($3โ€“$40) Stronger Trend CAPR
Beta / 30D Volatility Risk Regime 1.48ฮฒ ยท 73% Vol 1.52ฮฒ ยท 152% Vol Lower Realized Risk SVRA
Unified Institutional Score Composite Signal 57.7 / 100 (HOLD) 28.0 / 100 (SELL) Higher Composite SVRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SVRA vs CAPR Buy Guide
SVRA BREAKDOWN
92d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live SVRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAPR CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 89th %ile
IV Regime Extreme (>80th %ile)
Live CAPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SVRA nor CAPR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.